An Open-Label, Randomized Study with a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children from 1 Year to Less Than 18 Years Old with Systemic Juvenile Idiopathic Arthritis (JAHU)

Principal Investigator

Dr Kathryn Bailey

Contact us

Email: childrensresearch@ouh.nhs.uk

IRAS number

264683